About

Our story

In 1906, Dr. Alois Alzheimer identified the neuropathological hallmarks of the disease that now bears his name—a devastating condition marked by lipid dysregulation and one of humanity’s most profound medical and societal challenges.

MCMVI, the Roman numeral for the pivotal year, embodies MCM6's founding spirit. We confront these major discovery and clinical challenges of Alzheimer’s disease through innovative science, determination and compassion to restore hope for patients and families worldwide.

Close-up of cell molecules with circular and geometric shapes described in black and white with a dotted pattern.

Our mission

MCM6 is driven by a bold mission: to redefine Alzheimer’s disease and related cognitive impairments by restoring lipid homeostasis.

We are committed to delivering transformative, precision therapeutics that target the root causes of neurodegenerative diseases.

A digitally enhanced image of a human brain with glowing purple neural pathways against a black background.